Tech Company Financing Transactions
May Health Funding Round
May Health secured a $25 million Series B funding round on 5/13/2024. Investors included Bpifrance, Trill Impact Ventures and Avestria Ventures.
Transaction Overview
Company Name
Announced On
5/13/2024
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors
Bpifrance (Lead Investor) (Jean-Francois Morin)
Trill Impact Ventures (Lead Investor) (Nina Rawal)
Proceeds Purpose
The company intends to use the funds to support its growth and advance its Ovarian Rebalancing� therapy through the pivotal REBALANCE Study, evaluating its potential to address PCOS-related infertility.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
3489 Edison Way
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Undisclosed
Website
Email Address
Overview
We were founded in 2017 by the Paris-based accelerator MD Start. We're a team of seasoned MedTech entrepreneurs with deep experience in product development, validation, and launch. We want more for people suffering from Polycystic Ovary Syndrome (PCOS) and infertility resulting from PCOS.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anne Morrissey
Chief Financial Officer
Steve Bonelli
Chief Medical Officer
Edward Evantash
Chief Technical Officer
Hugh Magen
VP - Operations
Christina Hawley
VP - Operations
Scott Morimune
VP - Regulatory Affairs
Cindy Domecus
VP - Regulatory Affairs
Rich Ferrick
Browse more venture capital transactions:
Prev: 5/13/2024: Tiney venture capital transaction
Next: 5/13/2024: CereVasc venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs